We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $91.6B Turnover 10.68%
1-Year Est. Return 29.2%
This Fund
S&P 500
This Quarter Est. Return
+17.62%
1 Year Est. Return
+29.2%
3 Year Est. Return
+76.81%
5 Year Est. Return
+86.62%
10 Year Est. Return
+295.59%
AUM
$91.6B
AUM Growth
+$9.19B
Cap. Flow
-$1.24B
Cap. Flow %
-1.35%
Top 10 Hldgs %
34.81%
Holding
4,393
New
231
Increased
1,584
Reduced
1,622
Closed
238
Avg Time Held Equity + Options
7.2 years
Top 10 Avg Time Held Equity + Options
6.5 years
Top 20 Avg Time Held Equity + Options
5.3 years
Avg Time Held Equity only
7.2 years
Top 10 Avg Time Held Equity only
6.5 years
Top 20 Avg Time Held Equity only
5.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.23%
2 Technology 15.14%
3 Financials 7.27%
4 Healthcare 5.74%
5 Industrials 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CTA icon
4126
Simplify Managed Futures Strategy ETF
CTA
$1.41B
$40 ﹤0.01%
+1
New +$30
2026 Q2
0 quarters
CGC icon
4127
Canopy Growth
CGC
$286M
$33 ﹤0.01%
35
-72
-67% -$76
2018 Q3
31 quarters
AKO.B icon
4128
Embotelladora Andina Series B
AKO.B
$4.9B
$29 ﹤0.01%
1
– –
2014 Q4
46 quarters
BFRIW icon
4129
Biofrontera
BFRIW
$7.46K
$27 ﹤0.01%
1,000
– –
2023 Q1
13 quarters
EVF icon
4130
Eaton Vance Senior Income Trust
EVF
$86.7M
$20 ﹤0.01%
4
– –
2013 Q2
52 quarters
LE icon
4131
Lands' End
LE
$283M
$10 ﹤0.01%
+1
New +$11
2026 Q2
0 quarters
OM icon
4132
Outset Medical
OM
$77.1M
$9 ﹤0.01%
2
– –
2021 Q3
19 quarters
CLRB icon
4133
Cellectar Biosciences
CLRB
$11.5M
$8 ﹤0.01%
3
– –
2014 Q3
47 quarters
VAL.WS icon
4134
Valaris Ltd Warrants
VAL.WS
$1B
$8 ﹤0.01%
1
– –
2021 Q2
20 quarters
DAIC icon
4135
CID HoldCo Inc
DAIC
$2.76M
$5 ﹤0.01%
3
-1
-25% -$4
2025 Q3
3 quarters
MREO icon
4136
Mereo BioPharma
MREO
$45M
$4 ﹤0.01%
13
– –
2021 Q4
18 quarters
SITC icon
4137
SITE Centers
SITC
$196M
$4 ﹤0.01%
1
-74
-99% -$386
2013 Q2
52 quarters
WKHS icon
4138
Workhorse Group
WKHS
$28.4M
$3 ﹤0.01%
1
-1
-50% -$3
2022 Q4
14 quarters
BTAI icon
4139
DELISTED
BioXcel Therapeutics
BTAI
$1 ﹤0.01%
1
– –
2020 Q1
25 quarters
ABX icon
4140
Abacus Global Management
ABX
$812M
– –
-36
Closed -$284 –
ACLX icon
4141
DELISTED
Arcellx
ACLX
– –
-909
Closed -$104K –
AHCO icon
4142
AdaptHealth
AHCO
$803M
– –
-60
Closed -$714 –
AIV icon
4143
Aimco
AIV
$237M
– –
-131
Closed -$533 –
AL icon
4144
DELISTED
Air Lease Corp
AL
– –
-15,655
Closed -$1.02M –
ALAR icon
4145
Alarum Technologies
ALAR
$10.5M
– –
-1,937
Closed -$11.5K –
ALT icon
4146
Altimmune
ALT
$412M
– –
-890
Closed -$2.74K –
AMWD icon
4147
DELISTED
American Woodmark
AMWD
– –
-18,383
Closed -$732K –
ANNX icon
4148
Annexon
ANNX
$711M
– –
-77
Closed -$427 –
AOM icon
4149
iShares Core Moderate Allocation ETF
AOM
$1.95B
– –
-239
Closed -$11.3K –
APLS icon
4150
DELISTED
Apellis Pharmaceuticals
APLS
– –
-1,380
Closed -$55.5K –

Similar funds

US Bancorp's Q2 2026 Portfolio in Review

As of Q2 2026, US Bancorp held 4,393 positions worth $91.6B, up 11% from $82.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

US Bancorp's Q2 2026 filing shows 231 new, 1,584 increased, 1,622 reduced and 238 closed positions. Its largest new stake was Honeywell Aerospace: 400,519 shares worth $88.5M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.04B.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.

  • US Bancorp's largest Q2 2026 buy was Honeywell Aerospace: 400,519 shares worth $88.5M.
  • US Bancorp added most to Schwab US Large- Cap ETF in Q2 2026, an estimated $775M increase.
  • US Bancorp's biggest Q2 2026 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.04B.
  • US Bancorp fully exited Coterra Energy in Q2 2026, selling an estimated $68.5M.
  • US Bancorp's ten largest holdings make up 35% of its $91.6B portfolio in Q2 2026.
  • US Bancorp opened 231 new positions and closed 238 in Q2 2026.
  • US Bancorp's portfolio value rose 11% quarter-over-quarter to $91.6B.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.